Elegance in (bio)Engineering

In a complex world, filled with convoluted problems, elegant solutions are a soothing balm. They wrangle order out of borderline chaos. They make the overwhelmingly complex feel approachable.

Science loves elegance. Elegant solutions are associated with higher reproducibility across different methodologies. As a scientist, devising an elegant experimental design is almost a holy grail. It’s possible, yet rare.

But what exactly is an elegant experiment, or more broadly, an elegant solution? It’s a concept that has felt obvious for some time, but attempts to articulate it felt (ironically) inelegant. Then I came across the following:

At last, an elegant description of elegant solutions. In this model, there are two ways to make your solution more elegant: addressing more variables with the same simple solution, or finding a simpler way to solve the same complex problem. What’s most important is that it captures elegance not as an absolute value, but as contextual to the challenge being addressed.

Science loves elegance, and so too does engineering. In engineering, elegance is associated with solutions that are less prone to failure, more resilient, and more predictable. I think that this mutual appreciation of elegance has made the framing of engineering biology all the more attractive.

Whether through science or engineering, we’re trying to work with the most fundamental dynamics in a system to make them as reliable and consistent as possible. But how we go about doing so, how we apply the quest for elegance as a value, makes the difference in whether we will achieve true bio-innovation. A blind application of engineering elegance will often fail attempts at meaningful bio-innovation. Why?

Because elegance is contextual.

Share

Engineering emerged from working with materials that, ideally, don’t change across their service life. Steel beams change as a result of mechanical stress over time, but the molecular structure is quite stable. The expectation is that the conduction pathways of a circuit board perform the same today as they will tomorrow.

This stability is foundational to how engineering principles developed. When you assume your materials will maintain their properties, you design accordingly: you can calculate tolerances, you can predict failure modes, and you have reasonable confidence that you know all of the variables you’re working with. Reducing the number of moving parts is a viable path to simplifying your solution.

Of course, there is still change over time. Concrete only lasts so long. An unanticipated physical impact weakens segments of steel. Some of these changes can be accounted for in the design and engineering process, others through maintenance schedules. In the vast majority of cases, there are no surprise changes, spontaneous shifts, or adaptations.

This stability enables how we commonly define engineering success: creating systems that maintain their designed state. A successful bridge performs as designed, year after year. A successful manufacturing process produces identical outputs with minimal variation. Consistency is the goal. Deviation is a form of failure.

Naturally, engineering seeks to reduce variables, standardize components, and build redundancy through duplication. In turn, the reduction in variability allows for simpler solutions to be introduced, resulting in a more elegant solution. In the context of biology, there is a risk of misidentifying biological elegance as complexity, because traditional engineering frameworks weren’t designed to evaluate systems that use change to maintain function.

Traditional engineering maintains function and achieves elegance by avoiding change.

Biology can be stable, but it is never static; static biology is dead. The dynamism of biology is critical to the maintenance of stability, but it also means that the system itself is always changing. This isn’t a quality control problem to be solved. This dynamism is what enables life itself.

Consider a single bacterial cell maintaining its metabolism in a stable state. The exact nutrients that are closest by and most available shift from moment to moment, and the cell adapts to that. Structures assemble and disassemble according to the needs of the cell. The cell from 24 hours ago is molecularly distinct from the cell now, yet both are functioning correctly. All this change comes with a huge benefit - this cell can survive environmental changes that would destroy a static system.

Let’s take a more complex example: your own body. Right now, if you were to screen every cell in your bloodstream, you would likely detect some cancerous cells. But most of you reading this will never develop a diagnosable cancer. How could this be?

Through the engineering lens, the development of a cancerous cell is itself a form of quality control failure. But the pressures of evolution exert themselves at endpoints. The development of some cancerous cells isn’t actually a problem; it’s the development of a cancer that impacts the body’s functioning that must be avoided.

The development of the cancerous cell itself is, in fact, the result of that cell escaping many quality control mechanisms that would generally prevent this outcome. But the sheer volume of cells across the body means that some will make it this far. There are still more processes in the body that can prevent the formation of a diagnosable cancer; the immune system will detect many of these cells and destroy them, or when these cells try to leave the bloodstream and embed in a tissue, that tissue can reject them.

It would be easy, if you only consider the development of cancerous cells, to dismiss these biological solutions as inelegant. They are, in fact, complex. But it’s also a mis-assessment of the multiplicity of variables; by only considering these metabolic processes in the context of cancer, you have not taken all of the variables into account.

Because the very processes that create the risk of cancer development are the processes that enable robust survival under variable conditions. That is, for our ability to adapt, survive, and even thrive in the face of huge changes, we pay the price of the risk of cancer. The correct multiplicity of variables to use in the elegance calculation are the requirements for us to survive in an ever-changing world. And to achieve this, we have the same simplicity of solution.

With the proper context, this complex solution is profoundly elegant. The elegance ratio holds: a handful of cellular mechanisms (division, repair, immune surveillance) work across a multitude of variables to solve for many biological needs (healing wounds, fighting infections, adapting to stress, enabling reproduction).

Biological resiliency is inevitably tethered to variability because biology maintains function through constant change.

A great way to see shared principles applied very differently is to look at feedback loops. Both engineering and biology use feedback loops, and the elegance of implementation is context-dependent.

Let’s use the example of systems designed to maintain temperature. In an engineered system, a thermostat monitors temperature and activates heating or cooling to return the system to the target. The efficiency with which it can heat or cool is dependent on the systems installed, which largely depend on the common environmental conditions and the temperature desired. The goal is consistency, and the mechanisms of heating and cooling don’t change when the local context, like the weather outside, or even the thermostat setting, is changed. That is, the heater you installed is the one that will always be activated when heat is needed, and the air conditioner you installed is the one that will always be activated when cooling is needed.

Biological feedback loops are different. You may have heard that the average human body temperature is 98.6° F, but the keyword in that is average. Your body’s temperature set point - and the mechanism used to reach that temperature - changes depending on your context. Whether you’re awake or asleep, exercising, have recently eaten, what you ate, and whether you have an infection are just some of the variables that change the set point of your body temperature. And depending on what temperature the body is trying to reach or maintain, different behavioral and cellular mechanisms will be activated. When I am standing still in a cold room, different mechanisms are used to keep me warm than when I’m out running in the snow.

What looks on the surface like complexity in the biological system is, in fact, incredible efficiency at play. It’s as though your house HVAC system is taking into account who is in what room, at what time of day, what temperature is needed for the given activity, and then creating the conditions for that using a combination of multiple systems, depending on what is most efficient at that precise moment. The engineering complexity would be phenomenal with such a multitude of mechanisms.

The difference between the biological elegance and what would be engineering complexity is the extent to which all of those systems maintaining temperature in the body are useful for other critical body functions at the same time. The heat produced as a by-product of muscular contraction and relaxation is used to maintain my body temperature during my winter run. In the summer, rerouting bloodflow to the skin to dispel heat takes advantage of the fact that the entire cardiovascular system has to run anyway; it’s like altering the flow rate on a couple of valves rather than fundamentally starting a new process.

The key is context. If you look only at a single biological process, and not everything it contributes to, it will appear unnecessarily complex. But when evaluated in the context of all of the integrated systems, biology is remarkably elegant.

Share

Understanding biological integration makes it easy to see when simplification makes sense, and when it sacrifices significant biological advantages. Cell-free systems can demonstrate both.

As the name implies, you use only the molecules you need and remove all other biological systems. As benefits, you avoid crosstalk between signaling pathways, ensure you always have the same ratios of all of the molecules, and eliminate gene mutations.

This can be a great thing. Because of the control over what’s in the reaction, cell-free protein synthesis offers unmatched predictability. You can optimize conditions without worrying about keeping cells alive. The system behaves like traditional chemical engineering - mix your components, control your conditions, get your product. Through the lens of traditional engineering, these systems are elegant.

But there is a price. There’s no self-repair when components degrade. No adaptive response when conditions shift. No ability to regenerate the molecular machinery doing the work. This is why cell-free systems dominate single-batch protein production, while cellular systems dominate sustained manufacturing.

This trade-off can make sense for some applications. As in the case of protein synthesis, often you are trying to synthesize a protein because you need large amounts of a specific protein that is highly consistent. By using cell-free synthesis, you’ve identified which biological advantages you don’t need and deliberately removed the complexity that comes with them.

Put another way, you will have taken the great strength of biology - that change is constant and inevitable - and made it into a failure point. Our goal in developing biological technologies is not to make biology more like traditional engineering. It’s to develop engineering approaches that work with biological dynamism.

Because we understand that elegance is always contextual, we must also understand that these trade-offs should be considered carefully in the context of the problem being solved. Dogmas and default-decisions will result in missing the forest for the trees.

While there are no defaults to turn to, that doesn’t mean that you are trapped in ambiguity. In many ways, the game hasn’t changed at all: best practice is to turn to first principles.

While it’s important to constrain your problem scope as much as possible, you must maintain awareness of what you sacrifice when you look too narrowly at biology. If you remove biological integration in the pursuit of engineering simplicity, you are risking making the system incomplete while convincing yourself you made it simpler. Your solution will lose elegance because you’ve constrained the problem to exclude variables that biology was already solving for, like looking at the development of cancerous cells without considering the importance of adaptive survival.

The most elegant biological solutions may still look very complex. They often should because they solve for a multiplicity of variables, and a multiplicity of changing variables at that. Static systems don’t accommodate this.

True innovation in biology won’t come from making living systems behave like machines. It will come from learning to manipulate foundationally integrated systems that maintain their resiliency while optimizing for our goals.

When you look at the commercial options for DNA synthesis, you find that most companies are producing short sequences and have optimized for commodity metrics: speed, cost per base, and predictability. These solutions look elegant by traditional standards. Synthesizing long sequences initially appears less elegant; it currently requires more complex processes and longer timelines. But measured against what scientists actually need to accomplish, the calculation shifts. Long sequences enable chromosome-scale engineering, complete pathway construction, and experiments currently impossible with short fragments. At a glance, it may appear inelegant by engineering standards, but in the context of the biological goals enabled, elegance is apparent.

But procuring long sequences of DNA instead of several short sequences removes a lot of time- and resource-expensive processes for the receiving scientist, and enables entirely new approaches to biology. It’s not just solving a more complex problem; it’s enabling exploration of aspects of biology that are currently inaccessible.

We’ve achieved an inflection point. We’ve developed the ecosystem of tools required to work with biological complexity instead of engineering around it. Now we need to update our frameworks for both science and engineering to match our modern context.

We have the ability to pursue true bio-innovation. The breakthroughs we need go beyond optimizing existing methodologies and instead allow us to explore uncharted territory. These breakthroughs demand the recognition that biological complexity, properly understood, is biological elegance.